Friday, August 3, 2012

Daily News Digest: Reuters Health News Headlines - Yahoo! News

Daily News Alert
Yahoo! Alerts Yahoo! News | My Alerts | Edit Alert
Friday, August 3, 2012 8:30 PM PDT
Today's Reuters Health News Headlines - Yahoo! News:
Pigs under scrutiny at Midwest state fairs after flu outbreak
Fri,3 Aug 2012 04:42 PM PDT
Reuters -

Pigs stick their noses through a gate in the animal pavilion at Green Week Agriculture and Food fair in BerlinCOLUMBUS, Ohio (Reuters) - People flocking to agricultural fairs across the United States were warned on Friday to be cautious around pigs after reports this week of nearly a dozen swine flu cases linked to attendance at fairs where sick pigs were present. Ten new cases of influenza A (H3N2) variant were reported in Ohio and one in Indiana associated with attendance at agricultural fairs. Another case was reported from Hawaii. ...


Full Story
Top

Kids who drink soda may not drop milk
Fri,3 Aug 2012 03:44 PM PDT
Reuters -

Jessie Rodriguez, 8, and his brother Christopher Rodriguez, 3, drink soda as they sit in the shade on a hot day in downtown Los AngelesNEW YORK (Reuters Health) - Kids who drink sugary beverages are not necessarily switching to them and away from milk, according to a new study whose results contradict earlier evidence that sodas and other sweetened drinks are displacing more nutritious ones in kids' diets. Instead, based on surveys of more than 7,000 middle-schoolers, researchers found that some kids may drink less milk as they grow older, but their consumption of soda and other sweetened drinks remains fairly steady. Sugary drink intake did not appear to be rising to replace milk. ...


Full Story
Top

FDA to review Medivation, Astellas' prostate cancer drug in November
Fri,3 Aug 2012 03:36 PM PDT
Reuters -

Logo of Astellas Pharma Inc. is seen at the company's headquarters in Tokyo(Reuters) - Medivation Inc and Japanese partner Astellas Pharma Inc said the U.S. health regulator has set an action date of November 22 to review the companies' marketing application for their experimental prostate cancer drug. Codenamed MDV3100, the drug is designed to treat men with castration-resistant prostate cancer for whom chemotherapy has failed. The U.S. Food and Drug Administration last month granted the drug a priority review, a designation given to expedite the review of treatments that aim to cure serious diseases and fill unmet medical needs. ...


Full Story
Top

FDA approves Sanofi/Regeneron colon cancer drug
Fri,3 Aug 2012 03:19 PM PDT
Reuters -

Logo of French drugmaker Sanofi-Aventis is seen on the facade of their headquarters in Paris(Reuters) - The U.S. Food and Drug Administration said on Friday that it had approved the Sanofi SA and Regeneron Pharmaceuticals Inc drug Zaltrap for patients with metastatic colorectal cancer whose tumors have failed to respond to earlier treatment with chemotherapy. The infused medicine, to be taken in combination with standard chemotherapy, will compete with Roche Holding AG's Avastin and Bristol-Myers Squibb Co's Erbitux. Industry analysts say they expect Zaltrap to win peak annual sales of perhaps $300 million to $400 million, well below the widely used older treatments. ...


Full Story
Top

Thousands to be tested for hepatitis C in New Hampshire
Fri,3 Aug 2012 01:37 PM PDT
Reuters - BOSTON (Reuters) - Thousands of former patients at a New Hampshire hospital have been given permission to be tested to discover whether they were infected with the hepatitis C virus by a medical technician charged with stealing drugs and contaminating needles. The New Hampshire Department of Health and Human Services on Friday announced plans for testing about 3,300 former patients of Exeter Hospital who may have been infected. Any patient treated in the hospital's main operating rooms or intensive care unit between April 1, 2011 and May 25, 2012 may be at risk of infection. ... Full Story
Top

U.S. FDA approves generic versions of Merck's Singulair
Fri,3 Aug 2012 01:13 PM PDT
Reuters -

A sample of the drug SingulairWASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday said it granted 10 drugmakers marketing approvals for the first generic forms of Singulair, the $5 billion-a-year asthma and allergy drug that is Merck & Co Inc's best-selling product. The drugmakers, whose cheaper versions of Singulair are expected to quickly steal two thirds of the branded product's sales, include Mylan Inc, Teva Pharmaceutical Industries Ltd and the Sandoz division of Novartis AG. ...


Full Story
Top

CPR often leads to broken ribs
Fri,3 Aug 2012 01:02 PM PDT
Reuters -

Mannequin used to teach CPR techniques is seen next to rescue teams as they take part in a drill simulating a chemical warfare incident in Tel AvivNEW YORK (Reuters Health) - A significant portion of the people who receive cardiopulmonary resuscitation may end up with broken ribs or other bones as a result, according to Korean researchers, who also found that some types of patients could be at higher risk than others. In a study of people admitted to Korean hospitals, close to one third of those resuscitated after having CPR ended up with at least one broken rib, while about four percent had a broken breast bone, or sternum. Dr. ...


Full Story
Top

How Elton John redeemed self from 'disgusting' past
Fri,3 Aug 2012 12:35 PM PDT
Reuters -

Musician Elton John delivers the keynote speech at the AIDS 2012 conference in WashingtonWASHINGTON (Reuters) - More than 20 years ago singer-songwriter Elton John was, by his own admission, living a disgusting life of self-pity and drug abuse. Then he met Ryan White. White was an American teenager who in 1984 contracted the virus that causes AIDS through a blood transfusion due to his hemophilia. He was expelled from school because of fear of the disease and became a vocal advocate of HIV/AIDS awareness and prevention. ...


Full Story
Top

Talon future hinges on FDA chemotherapy decision
Fri,3 Aug 2012 12:14 PM PDT
Reuters - (Reuters) - Talon Therapeutics Inc, largely backed by venture capital, is banking on U.S. regulatory approval for its version of a nearly 50-year-old chemotherapy drug, which it expects will open the door to new licensing deals. The Food and Drug Administration is set to decide by August 12 on Talon's application for Marqibo for treating certain adults with acute lymphoblastic leukemia (ALL) who have failed at least two other therapies. ... Full Story
Top

More minority women die in childbirth
Fri,3 Aug 2012 11:56 AM PDT
Reuters - NEW YORK (Reuters Health) - Minority women in the United States are more likely to die during or soon after childbirth than white women, according to a new study from the Centers for Disease Control and Prevention. Black, Hispanic and Asian women - and a handful of white women not born in the U.S. - accounted for 41 percent of all births nationwide between 1993 and 2006, but for 62 percent of pregnancy-related deaths, researchers found. "Everyone thinks the U.S. has great healthcare, which is definitely the case, but certainly there are populations in the U.S. ... Full Story
Top

Some Ugandan Ebola patients likely to survive - doctors
Fri,3 Aug 2012 11:49 AM PDT
Reuters -

Handout of de la Rosa, manager of the Ebola Emergency ward, is seen inside the hospital of Kigadi town in the Ugandan Western district of KibaaleKAMPALA (Reuters) - Some of the 32 Ebola patients in isolation at a government hospital in western Uganda's Kibaale district are responding to treatment and may be discharged soon, a health official said on Friday. The east African country has been battling an outbreak of the deadly Ebola virus which has so far killed 16 people. Health officer Dan Kyamanywa said on Friday there had been no new deaths in two days. "There are signs of optimism because a big number of the 32 patients we have in isolation are recovering. ...


Full Story
Top

U.S. woman's altruism starts chain of five kidney swaps, extending lives
Fri,3 Aug 2012 11:20 AM PDT
Reuters -

Brittman waits to take part in a five-way organ transplant swap in New YorkNEW YORK (Reuters) - A soon-to-be wed gay couple, a retired teacher and his wife, and two pairs of fathers and sons were among those whose lives were changed one extraordinary day this week when a 35-year-old single mother of four from North Carolina donated a kidney to a stranger in New York. "I'm not losing nothing," Honica Brittman said this week, sitting in a blue and white hospital gown before surgery in which she would give, for free, the initial kidney in a chain of five kidney transplants at the New York-Presbyterian Hospital/Columbia University Medical Center. ...


Full Story
Top

Time perception may be off in migraine sufferers
Fri,3 Aug 2012 08:40 AM PDT
Reuters - NEW YORK (Reuters Health) - People with migraines may feel like time passes a bit more slowly than it actually does, if a small study is correct. The difference in time perception seems subtle - it's seen in people's perception of milliseconds. But the findings help validate the common complaint of migraine sufferers that they feel a bit "off" at times, according to a headache specialist not involved in the study. The new research, reported in the journal Headache, involved 27 adults with migraines and the same number of headache-free adults the same age. ... Full Story
Top

Go girl! Women pushing to close sporting gender gap
Fri,3 Aug 2012 05:13 AM PDT
Reuters -

China's Ye Shiwen poses with her gold medal after winning the women's 200m individual medley final during the London 2012 Olympic Games at the Aquatics CentreLONDON (Reuters) - The phenomenal speeds reached by the teenage Chinese swimmer Ye Shiwen at the 2012 Olympics are raising questions about whether the gap between men and women in sport may one day disappear. Ye, who has so far won two gold medals and broken a world record at the London Games, clocked a time for the last, freestyle lap of her medley swim that rivaled the male champions. There's plenty of evidence to show the gender gap exists, and has done ever since women have competed alongside men in international sporting events. ...


Full Story
Top

Drug price negotiations to begin next month
Fri,3 Aug 2012 04:59 AM PDT
Reuters - LONDON (Reuters) - The British government and the pharmaceutical industry will start negotiations next month on a new framework for pricing drugs that is due to take effect from 2014, the two sides said on Friday. Health minister Andrew Lansley has championed a shift to "value-based pricing", raising concerns among drug companies that the government will end up setting prices for medicines based on a rigid assessment system. The industry fears that may not reward incremental innovations, stifling the uptake of new drugs. ... Full Story
Top



You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.
\"\"

No comments:

Post a Comment